Abstract |
The hepatopulmonary syndrome is a triad of liver disease, increased alveolar-arterial oxygen gradient and intrapulmonary vascular dilatations. Manifestations include orthodeoxia, platypnoea and hyperdynamic circulation. Intrapulmonary vascular abnormalities, perhaps mediated by nitric oxide, cause hypoxaemia by shunting, a perfusion-diffusion defect, and ventilation-perfusion mismatching. Contrast-enhanced echocardiography is the method of choice for demonstrating pulmonary vascular abnormalities, although perfusion lung scanning is a more specific and sensitive test. Angiography is best reserved for patients with poor response to 100% oxygen and defines whether vascular dilatations are of the diffuse 'spongy' type or, less commonly, discrete arteriovenous communications amenable to embolization. About 80% of patients with the hepatopulmonary syndrome eventually have improved oxygenation after liver transplantation, thereby making worsening hypoxaemia the primary indication for transplantation in many instances. Nevertheless, severe hypoxaemia carries a peri-operative mortality of 30% and reliable predictors of successful outcome after transplantation remain to be determined.
|
Authors | L S Aboussouan, J K Stoller |
Journal | Bailliere's best practice & research. Clinical gastroenterology
(Baillieres Best Pract Res Clin Gastroenterol)
Vol. 14
Issue 6
Pg. 1033-48
(Dec 2000)
England |
PMID | 11139353
(Publication Type: Journal Article, Review)
|
Copyright | Copyright 2000 Harcourt Publishers Ltd. |
Topics |
- Combined Modality Therapy
- Female
- Hepatopulmonary Syndrome
(diagnosis, mortality, therapy)
- Humans
- Male
- Prognosis
- Severity of Illness Index
- Survival Rate
|